Chapter 203: Authenticity

The press conference lasted until the afternoon.

Mainly some reporters from state media wanted to confirm whether what Tian Jiajia said was true.

To this end, CCTV reporters also connected with well-known AIDS experts to ask Tian Jiajia questions.

They are afraid that this matter will be reported without proving its authenticity, and if what Tian Jiajia said is false, then China will make a big scandal in front of the whole world.

But even so, after the interview, many official media did not dare to believe that Tian Jiajia had really developed a special drug for AIDS based on the test video and experimental materials provided by Tian Jiajia.

Therefore, after the press conference, some unofficial media reported on the incident, while most mainstream official media, such as CCTV, only reported that Tian Jiajia may have developed a special drug for AIDS, and the specific authenticity needs to be further investigated.

The official media reported on the incident in a conservative manner, but even so, the news of Tian Jiajia's research on a special drug for AIDS spread all over the Chinese Internet overnight.

However, abroad, the incident did not cause much trouble.

Immediately after several foreign media outlets reported on the incident, more media outlets came forward to refute it.

In the end, several media outlets that reported the news also came forward to apologize, saying that the information was untrue.

In such a situation, as long as you are a little smart-minded, you can guess that these companies must have touched the interests of some people, and then they were suppressed.

The day after Yang Xin and Tian Jiajia held a press conference, an official contacted Tian Jiajia to investigate and confirm the authenticity of the AIDS drug.

The state attaches great importance to this matter, and China has only one million of the more than 40 million AIDS patients in the world.

Just like artemisinin, this drug has played a great role in maintaining friendly relations between China and Africa.

On the second day of the press conference, Tian Jiajia returned to the capital again.

For the next period of time, she needs to work with a group of AIDS experts to go through the animal experiment again.

As long as the effect of the special drug on animals can be proven, as Tian Jiajia said at the press conference, then the state will immediately approve Tian Jiajia's drug for human clinical trials.

At that time, the state will also open a green channel for special review, which will allow this drug to be marketed as soon as possible.

It's good that drugs can be marketed as soon as possible, but raw materials to make AIDS drugs are very scarce – such as high-altitude herbs and herbs from Siberia.

Therefore, it is imperative to artificially cultivate raw materials as soon as possible at the stage of drug review.

In this way, after the drug is approved on the market, there will be raw materials to produce this drug.

On Yang Xin's side, he vetoed the idea of letting Tian Jiajia take a stake in He Xin Pharmaceutical Company, and He Xin Pharmaceutical Company invested in the medicinal material planting base.

After all, He Xin Pharmaceutical Company has other shareholders, if Tian Jiajia uses this drug as a shareholder, wouldn't it be cheaper for others?

So the two decided, he and Tian Jiajia, each of them invested one billion yuan to establish a new pharmaceutical company.

Among the new pharmaceutical companies, Tian Jiajia occupies 60 percent of the shares with the results of AIDS special drugs, and Yang Xin accounts for the remaining 40 percent of the shares with the results of neutralizing Changshan toxicity and investing 1 billion yuan.

The prescription to neutralize Changshan's toxicity was redeemed by Yang Xin for three hundred points from the system mall, so this is his personal achievement, and Tian Jiajia's research results are separated.

After all, one yard is one yard, and he can't give this achievement to Tian Jiajia in vain.

If he hadn't exchanged this thing, Tian Jiajia wouldn't have a few years to think about researching AIDS special drugs.

Therefore, it is only natural that he will buy 40% of the company's shares with the results of the exchange of 300 points.

————

After the press conference, many media reported a lot on Tian Jiajia's development of a special drug for AIDS.

However, the authenticity of the AIDS drug is still under investigation, and all netizens across the country are looking forward to the results of the expert group's investigation.

Tian Jiajia provided finished HIV-specific drugs to several biological laboratories, and then the laboratories would find macaques and chimpanzees with HIV to test the drugs.

If the medicine is real and effective, then it is believed that the results will be available soon.

In the expectation of netizens, in less than half a month, there was good news from a national key biological laboratory.

In the experiment, three macaques and two chimpanzees mildly infected with HIV were killed after half a month of different doses of medication.

Just after the results of this laboratory came out, the good news came from several other laboratories and finally proved that this AIDS drug is real and effective.

The next day, the Central News Network officially released the news to the people of the whole country.

At the same time, the People's Daily also released the news on major platforms. He also congratulated Tian Jiajia on her achievements and thanked her for bringing hope to AIDS patients.

As the two largest state media outlets spoke, other media outlets began to reprint or publish their own press releases.

[17-year-old Tian Jiajia has developed a real and effective drug for AIDS, and has achieved the success of biological experiments, and will immediately conduct human clinical trials. 】

[Congratulations to Tian Jiajia, a young scientist in China, for his major scientific research achievements. 】

[AIDS special drug comes out, AIDS will no longer be a terminal disease!]

[Tian Jiajia, a 17-year-old genius scientist, developed a special drug for AIDS that has been proven to be true and effective by the national laboratory, and the gospel of AIDS patients is coming. 】

On this day, countless media outlets reported the news.

"Teacher, the Food and Drug Administration has approved the clinical trial of this drug. ”

On this day, Tian Jiajia called Yang Xin and told him good news.

"That's good, do you continue to follow up on the clinical trial or hand it over to the company's people?" asked Yang Xin Chaotian Jiajia.

The two have established a three-person pharmaceutical company, and Yang Xin asked He Qingqing to directly recruit a group of people from major pharmaceutical companies to form the company's team.

The president of this company is also temporarily served by He Qingqing, and after the company is on the right track, it will be handed over to professional managers.

"Leave it to the company, the drug has been researched, as long as there are no big problems, I am not ready to intervene, I am ready to continue to research new drugs." Tian Jiajia said to Yang Xin.

"What is the research on new drugs?" asked Yang Xin curiously.

"Let's study tumors!"

Tian Jiajia said: "At present, among the five major terminal diseases, rheumatoid and leukemia and AIDS have cures and drugs, but there are still many cancers that cannot be cured, so I want to start with cancer." Tian Jiajia said to Yang Xin.

"Okay, ambitious, the teacher supports you. Yang Xin encouraged.

Speaking of cancer, Yang's mother's lung cancer was cured by Yang Xin, but the treatment of cancer is too expensive for ordinary people to cure.

And that method later proved that the success rate was very low, and it was luck that Yang's mother was able to save it, so this treatment method could not be promoted on a large scale.